Navigation Links
Chemo Drug Improves Stomach Cancer Survival for Japanese Patients
Date:10/31/2007

Researchers aren't sure if drug would have same benefit for Caucasians

WEDNESDAY, Oct. 31 (HealthDay News) -- Treatment of stomach cancer with an experimental chemotherapy drug after surgery improved survival rates for Japanese patients, a new study found.

The results of the trial won't mean much for Americans with stomach cancer, because the drug, designated S-1, is classified as "investigational" in the United States. But the study results could add impetus to the use of drug and/or radiation therapy against stomach cancer, U.S. experts said.

"This is the third large study that demonstrates a significant benefit of adjuvant (combination) therapy either before or after surgery for gastric cancer," said Dr. Manish Shah, an assistant attending oncologist at Memorial Sloan-Kettering Cancer Center in New York City.

Until relatively recently, it had generally been thought that drug or radiation therapy for stomach cancer wouldn't accomplish much, Shah said. "With less than one-year survival with metastatic disease, there may have been a sense that it didn't do any good," he said.

Metastatic means that the gastric cancer has spread outside the stomach, establishing microscopic colonies beyond the reach of surgery. But the almost 1,060 participants in the Japanese trial were potentially curable with surgery, because the disease had not spread. Half were assigned S-1 treatment plus surgery, while the other half had surgery followed by observation alone.

The trial, scheduled to last three years, was stopped after 12 months, because the survival rate for the S-1 group was 80.1 percent, compared to 70.1 percent for the surgery-only group.

The findings are published in the Nov. 1 issue of the New England Journal of Medicine.

S-1 had been used in some U.S. trials but was abandoned because of the high rate of side effects, Shah said. Japanese people apparently metabolize the drug differently than Caucasians, minimizing its side effects, he said.

Other drugs are being used successfully against stomach cancer, as is radiation, said Dr. Jaffer Ajani, professor of medicine at the University of Texas M.D. Anderson Cancer Center in Houston. But surgery is the essential first step in treatment of stomach cancer, he said.

"Chemotherapy alone has never been shown to be beneficial," Ajani said.

The U.S. National Cancer Institute estimates that there are 21,260 new cases of stomach cancer among Americans each year, with 11,210 deaths.

"Treatment for my patients includes radiation and chemotherapy together," Ajani said. "Not for every patient, but for most patients."

Use of such adjuvant therapy for stomach cancer began slowly, with studies showing that "chemotherapy was better than not for patients with metastatic disease," Shah said. Later trials showed benefits for people whose cancers had not spread.

"For gastric cancer, since 2001, some kind of adjuvant therapy has been given here in the United States, along with radiation," Shah said.

More information

Complete information on stomach cancer is available from the U.S. National Cancer Institute.



SOURCES: Manish Shah, M.D., assistant attending oncologist, Memorial Sloan-Kettering Cancer Center, New York City; Jaffer Ajani, M.D., professor of medicine, University of Texas M.D. Anderson Cancer Center, Houston; Nov. 1, 2007, New England Journal of Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Chemotherapy Pill Has Fewer Side Effects Than IV
3. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
4. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
5. Therapy Boosts Chemotherapy Effects
6. Chemotherapy Effective for Bladder Cancer
7. Hope for Chemo-Resistant Leukemia Patients
8. New Method Of Delivering Chemotherapy
9. Drug That Is Found To Reduce Heart Damage from Chemo
10. The Benefits Of Chemotherapy For Women With Ovarian Cancer
11. New Compound Could Strengthen The Effect Of Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemo Drug Improves Stomach Cancer Survival for Japanese Patients
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
Breaking Medicine Technology: